SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.17 Cr | ₹3.46 Cr | ₹5.62 Cr | ₹5.62 Cr | ₹1.57 Cr |
What is the latest Contingent Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.17 Cr |
| Mar2024 | ₹3.46 Cr |
| Mar2023 | ₹5.62 Cr |
| Mar2022 | ₹5.62 Cr |
| Mar2021 | ₹1.57 Cr |
How is Contingent Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.17 Cr | 20.41 | |
| Mar2024 | ₹3.46 Cr | -38.45 | |
| Mar2023 | ₹5.62 Cr | 0.00 | |
| Mar2022 | ₹5.62 Cr | 257.96 | |
| Mar2021 | ₹1.57 Cr | - | |
Compare Contingent Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,039.1 Cr | -0.6% | 1.2% | 36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,804.0 Cr | -0.2% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,764.0 Cr | -2.4% | 9.1% | 13.4% | Stock Analytics | |
| CIPLA | ₹126,807.0 Cr | -5.7% | 4% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,099.0 Cr | -0.3% | 1.3% | 8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,707.0 Cr | 0.1% | 1.2% | -2.8% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -0.6% |
1.2% |
36.7% |
| SENSEX | 0.3% |
3.6% |
5.5% |
You may also like the below Video Courses